XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Option Activity Under Company's Equity Incentive Plans

The following table summarizes stock option activity under the Company’s 2018 Plan and related information:

 

 

 

Number of Shares

Underlying

Outstanding

Options

 

 

Weighted-

Average Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual Term

(Years)

 

Outstanding — December 31, 2021

 

 

2,603,630

 

 

$

7.70

 

 

 

7.46

 

Options granted

 

 

879,200

 

 

$

0.52

 

 

 

 

 

Options forfeited

 

 

(658,947

)

 

$

5.20

 

 

 

 

 

Options expired

 

 

(46,173

)

 

$

9.81

 

 

 

 

 

Outstanding — March 31, 2022

 

 

2,777,710

 

 

$

5.92

 

 

 

8.00

 

Exercisable — March 31, 2022

 

 

1,305,020

 

 

$

9.42

 

 

 

 

 

Summary of Weighted Average Valuation Assumptions Used to Estimate Fair Value of Employee Stock Options The fair value of employee stock options was estimated using the following weighted-average assumptions:

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Employee Stock Options:

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

1.87

%

 

 

0.69

%

Expected term (in years)

 

 

6.1

 

 

 

6.1

 

Dividend yield

 

 

 

 

 

 

Volatility

 

 

91.54

%

 

 

93.83

%

Weighted-average fair value of stock options granted

 

$

0.39

 

 

$

4.70

 

Summary of Stock-Based Compensation Recognized

Total stock-based compensation expense recognized was as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2022

 

 

2021

 

Research and development

 

$

128

 

 

$

369

 

General and administrative(1)

 

 

387

 

 

 

657

 

Total stock-based compensation expense

 

$

515

 

 

$

1,026

 

 

 

(1)

Included in general and administrative stock-based compensation for the three months ended March 31, 2022 is stock-based compensation expense related to 32,684 shares of common stock issued to certain board members in lieu of their cash compensation.